nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Cognitive impairment—Dexamethasone—ankylosing spondylitis	0.0436	0.0436	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Betamethasone—ankylosing spondylitis	0.0436	0.0436	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Prednisone—ankylosing spondylitis	0.0379	0.0379	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Methotrexate—ankylosing spondylitis	0.0317	0.0317	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisolone—ankylosing spondylitis	0.031	0.031	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methylprednisolone—ankylosing spondylitis	0.0289	0.0289	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Triamcinolone—ankylosing spondylitis	0.0285	0.0285	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Methylprednisolone—ankylosing spondylitis	0.0284	0.0284	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Betamethasone—ankylosing spondylitis	0.0263	0.0263	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Dexamethasone—ankylosing spondylitis	0.0263	0.0263	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Betamethasone—ankylosing spondylitis	0.0258	0.0258	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Dexamethasone—ankylosing spondylitis	0.0258	0.0258	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Prednisone—ankylosing spondylitis	0.0229	0.0229	CcSEcCtD
Trihexyphenidyl—Blindness—Triamcinolone—ankylosing spondylitis	0.0226	0.0226	CcSEcCtD
Trihexyphenidyl—Blindness—Methylprednisolone—ankylosing spondylitis	0.0226	0.0226	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisone—ankylosing spondylitis	0.0225	0.0225	CcSEcCtD
Trihexyphenidyl—Blindness—Betamethasone—ankylosing spondylitis	0.0205	0.0205	CcSEcCtD
Trihexyphenidyl—Blindness—Dexamethasone—ankylosing spondylitis	0.0205	0.0205	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methotrexate—ankylosing spondylitis	0.0191	0.0191	CcSEcCtD
Trihexyphenidyl—Delusion—Methylprednisolone—ankylosing spondylitis	0.0177	0.0177	CcSEcCtD
Trihexyphenidyl—Mydriasis—Prednisolone—ankylosing spondylitis	0.0171	0.0171	CcSEcCtD
Trihexyphenidyl—Delusion—Betamethasone—ankylosing spondylitis	0.0161	0.0161	CcSEcCtD
Trihexyphenidyl—Delusion—Dexamethasone—ankylosing spondylitis	0.0161	0.0161	CcSEcCtD
Trihexyphenidyl—Delusion—Prednisone—ankylosing spondylitis	0.014	0.014	CcSEcCtD
Trihexyphenidyl—Memory impairment—Prednisone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisolone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.0107	0.0107	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00977	0.00977	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00977	0.00977	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisolone—ankylosing spondylitis	0.00907	0.00907	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00886	0.00886	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00864	0.00864	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisone—ankylosing spondylitis	0.00851	0.00851	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00806	0.00806	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00806	0.00806	CcSEcCtD
Trihexyphenidyl—Dry skin—Betamethasone—ankylosing spondylitis	0.00756	0.00756	CcSEcCtD
Trihexyphenidyl—Dry skin—Dexamethasone—ankylosing spondylitis	0.00756	0.00756	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00702	0.00702	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Trihexyphenidyl—Weight decreased—Betamethasone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Trihexyphenidyl—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Trihexyphenidyl—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00625	0.00625	CcSEcCtD
Trihexyphenidyl—Hallucination—Dexamethasone—ankylosing spondylitis	0.00568	0.00568	CcSEcCtD
Trihexyphenidyl—Hallucination—Betamethasone—ankylosing spondylitis	0.00568	0.00568	CcSEcCtD
Trihexyphenidyl—Weight decreased—Prednisone—ankylosing spondylitis	0.00562	0.00562	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Trihexyphenidyl—Hallucination—Prednisone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisolone—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methotrexate—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Trihexyphenidyl—Confusional state—Methylprednisolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Trihexyphenidyl—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Trihexyphenidyl—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Trihexyphenidyl—Agitation—Prednisone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Trihexyphenidyl—Vision blurred—Methotrexate—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Trihexyphenidyl—Asthenia—Triamcinolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Trihexyphenidyl—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Trihexyphenidyl—Rash—Prednisolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Trihexyphenidyl—Headache—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Trihexyphenidyl—Constipation—Prednisone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Trihexyphenidyl—Confusional state—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Trihexyphenidyl—Dizziness—Triamcinolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Trihexyphenidyl—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Trihexyphenidyl—Asthenia—Dexamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Trihexyphenidyl—Asthenia—Betamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Trihexyphenidyl—Vomiting—Triamcinolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Trihexyphenidyl—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Trihexyphenidyl—Rash—Triamcinolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Trihexyphenidyl—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Trihexyphenidyl—Rash—Methylprednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Trihexyphenidyl—Headache—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Trihexyphenidyl—Headache—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Trihexyphenidyl—Dizziness—Dexamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Trihexyphenidyl—Dizziness—Betamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Trihexyphenidyl—Nausea—Triamcinolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Trihexyphenidyl—Nausea—Methylprednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Trihexyphenidyl—Somnolence—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Vomiting—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Trihexyphenidyl—Vomiting—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Trihexyphenidyl—Rash—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Trihexyphenidyl—Rash—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Trihexyphenidyl—Headache—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Trihexyphenidyl—Headache—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Trihexyphenidyl—Asthenia—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Trihexyphenidyl—Nausea—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Trihexyphenidyl—Nausea—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Trihexyphenidyl—Vomiting—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Trihexyphenidyl—Rash—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Trihexyphenidyl—Headache—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Trihexyphenidyl—Asthenia—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Trihexyphenidyl—Dizziness—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Trihexyphenidyl—Vomiting—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Trihexyphenidyl—Rash—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Trihexyphenidyl—Headache—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Trihexyphenidyl—Nausea—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
